已收盤 07-18 16:00:00 美东时间
-0.005
-0.09%
多家机构首予Amrize买入评级,目标价53~62美元;HC Wainwright & Co.上调内克塔治疗目标价至120美元,维持"买入"评级>>
06-25 08:39
JMP Securities analyst Rustam Kanga initiates coverage on Backblaze (NASDAQ:BLZE) with a Market Outperform rating and announces Price Target of $7.
06-24 21:39
Backblaze (NASDAQ:BLZE) closes its senior secured revolving credit facility in an aggregate principal amount of up to $20M, of which an aggregate amount of up to $3M will be available through a letter...
06-05 23:27
Backblaze shares are trading higher after the company reported better-than-expe...
05-08 22:47
Companies Reporting Before The Bell • Wallbox (NYSE:WBX) is estimated to report...
05-07 16:33
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1106501041932570625.png</p><span style="color:#999999;">编者按:每日追踪华尔街最新评级与目标价,挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Roth MKM:维持CervoMed Inc.(CRVO)"买入"评级,目标价从7美元升至15美元</p> <p>• Oppenheimer:维持Trevi Therapeutics(TRVI)"跑赢大市"评级,目标价从
03-12 11:01
Needham analyst Matt Dezort initiates coverage on Backblaze (NASDAQ:BLZE) with a Buy rating and announces Price Target of $8.
03-11 19:03
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1102154574572916737.png</p><span style="color:#999999;">编者按:每日追踪华尔街最新评级与目标价,挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Piper Sandler:维持Prothena Corp(PRTA)"超配"评级,目标价从94美元升至110美元</p> <p>• Stifel:维持GH Research(GHRS)"买入"评级,目标价从18美元升至3
02-28 09:50
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1101791398596456448.png</p><span style="color:#999999;">编者按:每日追踪华尔街最新评级与目标价,挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Piper Sandler:维持Prothena Corp(PRTA)"超配"评级,目标价从94美元升至110美元</p> <p>• HC Wainwright & Co.:维持Karyopharm Therape
02-27 11:06
Backblaze, Inc. ( ($BLZE) ) has released its Q4 earnings. Here is a breakdown o...
02-26 11:56